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This study shows that prominent histologic, structural, and
gene expression abnormalities are observed in macroscop-
ically healed gastric epithelium. Results suggest that the site
of ulcer healing is the site of ulcer recurrence and a potential
source of further disease.
BACKGROUND & AIMS: The peptic ulcer heals through a
complex process, although the ulcer relapse often occurs several
years later after healing. Our hypothesis is that even after visual
evidence of healing of gastric ulceration, the regenerated
epithelium is aberrant for an extended interval, increasing sus-
ceptibility of the regenerated epithelium to damage and further
diseases.
METHODS: Gastric ulcers were induced in mice by serosal
topical application of acetic acid.
RESULTS: Gastric ulcers induced by acetic acid visually healed
within 30 days. However, regenerated epithelial architecture
was poor. The gene proﬁle of regenerated tissue was abnormal,
indicating increased stem/progenitor cells, deﬁcient differenti-
ated gastric cell types, and deranged cell homeostasis. Despite
up-regulation of PDX1 in the regenerated epithelium, no mature
antral cell type was observed. Four months after healing, the
regenerated epithelium lacks parietal cells, trefoil factor 2
(TFF2) and (sex-determining region Y)-box 9 (SOX9) remain up-
regulated deep in the gastric gland, and the Na/H exchanger 2 (a
TFF2 effector in gastric healing) remains down-regulated.
Gastric ulcer healing was strongly delayed in TFF2 knockout
mice, and re-epithelialization was accompanied with mucous
metaplasia. After Helicobacter pylori inoculum 30 days after ul-
ceration, we observed that the gastric ulcer selectively relapses
at the same site where it originally was induced. Follow-up
evaluation at 8 months showed that the relapsed ulcer was
not healed in H pylori–infected tissues.
CONCLUSIONS: These ﬁndings show that this macroscopically
regenerated epithelium has prolonged abnormal cell distribu-
tion and is differentially susceptible to subsequent damage by
H pylori. (Cell Mol Gastroenterol Hepatol 2016;2:625–647;
http://dx.doi.org/10.1016/j.jcmgh.2016.05.005)
Keywords: Gastric Ulcer Healing; Metaplasia; H pylori; SOX9;
TFF2; NHE2.astric ulcers, excavations that extend from theGepithelial lining to the muscle layer of the stomach,
heal through a dynamic process that seeks to restore normal
architecture and function to a site of deep tissue erosion.
Depending on the size of the erosion, it can take days or
months for healing to occur. The mechanisms underlying
ulcer healing are not fully understood, although the beneﬁcial
effects of Helicobacter pylori eradication or inhibition of acid
secretion are well established1–3 to accelerate macroscopic
healing of the epithelium over an ulcer bed. Many in-
vestigators have focused on ulcer healing by observing the
closure of the ulcer hole in short-term (<14 days) animal
models of experimental ulceration (or endoscopically in hu-
man beings), and developing drugs to accelerate this
macroscopic healing process in the preclinical models.1,2
Follow-up endoscopy is a common clinical practice.
Assessment of gastric ulcer healing usually is based on a
visual examination by endoscopy, and not typically on
microscopic assessment of mucosal healing.3 Several long-
term follow-up studies have shown a correlation between
a history of ulcer and subsequent cancer development.4–7
Interestingly, the risk of gastric cancer development in ul-
cer patients with successful H pylori eradication has been
reported to be reduced by only one third or less compared
with eradication failure patients.4,5,8,9 These results raise
the hypothesis that residual abnormalities in the regener-
ated epithelium after ulcer healing could increase the risk of
subsequent damage or disease.
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Figure 2. Gastric regen-
erated epithelium mor-
phology at day 30. Gastric
tissue was evaluated 30
days after ulcer induction.
Gross appearance and (A) 3-




(B) 2-dimensional (2D) z-
stack image. (C) Side view of
3D constricted image from
regenerated epithelium indi-
cated as white dotted rect-
angle in panel A.
September 2016 Imperfect Gastric Ulcer Healing 627Recent studies in rodents observed prominent histologic
and structural abnormalities in visually healed tissue at
least 28 weeks after ulcer induction, including poor differ-
entiation and/or degenerative changes in glandular cells,
increased connective tissue, and disorganized microvascular
arrays.1,3,10 Moreover, in the gastric glands of healed ulcer
tissue an up-regulation of trefoil factor 2 (TFF2) and mucin
(MUC)6 is accompanied by a lack of parietal cells,11,12
similar to the metaplastic state identiﬁed as a precursor ofFigure 1. (See previous page). Gastric regenerated epitheliu
tissue was evaluated (A) 2 days or (B) 30 days after ulcer induct
dotted rectangle on low-resolution image, and whole mount sta
Epithelium height was measured in an uninjured area (C, control)
vs control. Sections of gastric regenerated epithelium at experim
staining for HK-ATPase (HK: red) and cell nuclei (cyan), (D) H,K-A
high magniﬁcation of intact and regenerated epithelium, scale bgastric cancer.12–14 Interestingly, mice with genetic disrup-
tion of the Na/H exchanger isoform sodium hydrogen
exchanger 2 (NHE2) have atrophied parietal cells with up-
regulation of TFF2,15,16 and it has been shown that NHE2
is a downstream mediator of TFF2 for the gastric repair of
damage.16 Thus, it is unclear whether regenerated epithe-
lium fully returns to normal, and both TFF2 and NHE2 have
been implicated as important elements of gastric epithelial
homeostasis.m in an acetic acid–induced ulcer mouse model. Gastric
ion. Gross morphology with low resolution, high resolution of
ining with HK-ATPase (red) and nuclei (Hoechst33342: cyan).
and a regenerated area (Re). *Signiﬁcant difference at P < .05
ental day 30 after ulceration. Images show (C) H&E staining,
TPase (HK: red), and TFF2, or (E) NHE2 (green, bottom panel:
ar: 100 mm), nuclei (blue). Scale bar: 1 mm.
Figure 3. Gastric marker
expression in regener-
ated epithelium. Gastric
intact epithelium and re-
generated epithelium were
isolated 30 days after ulcer
induction. (A) Data show
Western blot images of HK-
ATPase (HK), GIF, TFF2,
DCLK1, NHE2, SOX9, or
GAPDH as indicated. (B)
Compiled analysis of West-
ern blots as in panel A, with
results normalized to
GAPDH. Results are pre-
sented as fold changes to
intact epithelium, means ±
SEM (N ¼ 4). *Signiﬁcant
difference at P < .05 vs
intact. Re, regenerated
epithelium. Heat map of
RNA expression of organ-
speciﬁc markers, including
(C) small intestine, gastric
corpus, and gastric antrum,
or (D) stem cell markers, in
the ulcer regenerated
epithelium. Data are repre-
sented as log2-transformed
gene expression levels in
the regenerated epithelium
in comparison with the un-
injured epithelium from the
same mouse stomach (N ¼
3). *P < .05, **P < .005 vs
uninjured tissue.
628 Aihara et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 5The markers of gastric corpus epithelial stem/progenitor
cells are largely unknown. The leucine-rich repeat-containing
G protein-coupled receptor 5 (Lgr5)þ cell now is recognized
as a stem cell in the antrum, small intestine, and colon.17
However, it is unlikely that Lgr5þ is present in gastric
corpus epithelial stem cells.18 It has been reported that
Lgr5þ cells are not involved in developing metaplasia in the
corpus in mice, whereas antral-type glands, based on the
composition of mucus, are observed in corpus regenerated
tissue.19 Currently, Troy-positive cells are identiﬁed as
quiescent stem-like cells that are expressed in the corpus
gland base in a subset of differentiated chief cells, however,
there is no active proliferation in the base of the gland in
intact tissue.12,20 In addition, SOX2 is expressed in cells
within the gastric adult stem/progenitor compartments andSOX2-positive cells have shown a capacity for self-renewal
and differentiation in the gastric corpus.21 In contrast, SOX9
is widely recognized as a stem/progenitor marker in several
tissues, and it has been reported that SOX9 is expressed
weakly in the neck/isthmus of the mouse and human gastric
corpus region, whereas SOX9 is up-regulated in abnormal
gastric epithelium.22–24
In the present study, we explored regenerated epithe-
lium morphology and gene proﬁle at 30 days after ulcera-
tion, which was visually healed. In addition, we asked if
gastric regenerated tissue returns to normal gastric
epithelial appearance during a long-term period. Moreover,
we asked if the site of regenerated tissue has greater sus-
ceptibility to damage, and we investigated the effect of H
pylori on ulcer regenerated epithelium.
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Animal Husbandry and Surgery
Experiments used C57BL/6J mice (Jackson Lab, Bar Har-
bor, ME), in-house bred TFF2 knockout (KO) mice (back-
crossed onto a C57BL/6J background until >90% of genomic
microsatellite markers were from C57BL/6J), and in-house
bred NHE2 (Slc9A2) KO mice (FVB/NJ background). Ani-
mals were fed a standard rodent chow diet and had free
access to water. All mice experiments were conducted ac-
cording to both Animal Welfare Act Regulations and the
Public Health Service Policy on Humane Care and Use of
Laboratory Animals. Mice were maintained in an Association
for Assessment and Accreditation of Laboratory Animal Care-
approved facility and all animal studies followed protocol 04-
03-08-01, which was approved by the Institutional Animal
Care and Use Committee of the University of Cincinnati.
Gastric ulcers were produced by acetic acid, according to
a previously described method with slight modiﬁcations.1 In
brief, under isoﬂurane anesthesia, the abdomen was incised
and the intact stomach was exposed. A microcapillary tube
(0.7 mm in diameter; Drummond Scientiﬁc, Co, Broomall,
PA) ﬁlled with acetic acid (99%) was placed in contact with
the exterior surface of the stomach corpus region and left in
place for 25 seconds. Buprenorphine hydrochloride (0.1
mg/kg intraperitoneal Buprenex; Rechkitt Benckiser Phar-
maceuticals, Inc, Richmond, VA) was given as pre-emptive
analgesia. After the acid was removed, the treated exterior
of the stomach was wiped with gauze, the abdomen was
closed, and the animals were maintained routinely with food
and water. By using this procedure, no incision was made to
the stomach as part of the ulcer induction.
To examine ulcer healing, animals were killed at 9 days,
30 days, 44 days, 4 months, or 8 months after ulceration,
and the stomach was removed and opened along the greater
curvature. The ulcer-induced area was found by serosal
observation of white discolored muscle tissue. The area
(mm2) of ulceration on the mucosal side was measured by a
digital caliper (Mitutoyo, Kanagawa, Japan). In some cases, H
pylori was gavaged at day 30 after the ulceration. Control
uninfected animals received Brucella broth vehicle (BD
Diagnostic Systems, Franklin Lakes, NJ).Preparation of H pylori
As we described previously,11 H pylori Sydney strain 1
were grown on Columbia blood agar plates (Remel, Lenexa,
KS) containing 5% deﬁbrinated horse blood (Colorado
Serum, Denver, CO), 0.2% b-cyclodextrin (Sigma, St. Louis,
MO), 50 mg/mL cyclohexamide (Sigma), 5 mg/mL vanco-
mycin (Sigma), and 10 mg/mL trimethoprim (Sigma) for 4
days. Bacteria harvested from the plate were grown in
Brucella broth (BD Diagnostic Systems) supplemented with
10% fetal bovine serum and a CO2 gas pack (BD Diagnostic
Systems) in a humidiﬁed microaerophilic chamber (BBL Gas
System with CampyPak Plus packs; BD Microbiology,
Sparks, MD) in an incubator at 37C for 16–18 hours
without shaking. Bacteria were collected by centrifuge at
2000 rpm for 5 minutes, and resuspended in Brucella broth
without serum. H pylori were diluted in 50% glycerol (1:100dilution) and counted in a hemocytometer. Each mouse
received 200 mL Brucella broth containing 106 H pylori
bacteria. Control mice (uninfected group) received 200 mL
of Brucella broth alone.Quantiﬁcation of H pylori Levels in Mouse
Stomach Tissue
The wet weight was measured for the mouse gastric
tissue collected from intact and ulcerated tissue. Tissue was
homogenized by Tissue Tearor (model 985370-395; Bio-
Spec Products, Bartlesville, OK) in 1 mL saline and 1:10
dilutions were spread on a Columbia blood agar plate con-
taining 5% deﬁbrinated horse blood, 50 mg/mL cyclo-
hexamide, 5 mg/mL vancomycin, and 10 mg/mL
trimethoprim. Plates were incubated for 5 days at 37C in a
humidiﬁed microaerophilic chamber with a CO2 gas pack.
Colonies were counted and data were normalized using the
tissue weight and expressed in colony forming units per
gram of tissue.Quantitative Real-Time Polymerase
Chain Reaction
Total RNA was isolated from either the intact or regen-
erated epithelium of the stomach using TRI Reagent (Molec-
ular Research Center, Inc, Cincinnati, OH) and single-stranded
cDNAwas synthesized by the iScript cDNA synthesis kit (Bio-
Rad, Hercules, CA). Quantitative real-time polymerase chain
reaction (PCR) was performed using the SYBR Green PCR
Master Mix (Applied Biosystems, Foster, CA) with the
following speciﬁc primers: hydrogen potassium exchanger
adenosine triphosphatase (HK-ATPase) (forward: 5’-
AGATGGTGTTTGCTCGAACC-3’ and reverse: 5’-TCCAGCAA-
GATCATGTCAGC-3’), TFF2 (forward: 50-GCAGTGCTTT-
GATCTTGGATGC-30 and reverse: 50-TCAGGTTGGAAAAGC
AGCAGTT-30), NHE2 (forward: 50-CTTCTGATTCGGGAAAACA-
30 and reverse: 50-ATCAGGATCTCCTTGGCTTG-30), SOX9
(forward: 5’-CGGAACAGACTCACATCTCTCC-3 and reverse:
’5’-GCTTGCACGTCGGTTTTGG-3’), or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (forward: 5’-AAC-
GACCCCTTCATTGAC-3’ and reverse: 5’-TCCACGACA-
TACTCAGCAC-3’). Each PCR ampliﬁcation was performed in
duplicate wells in a StepOnePlus Real-Time PCR System
(Applied Biosystems).Immunoﬂuorescence
Mouse intact or regenerated stomach tissue was
embedded in optimal cutting temperature compound
(Sakura Finetek, Inc, Torrance, CA), frozen, and stored at
-80C. Serial cryosections (10 mm) were prepared by cryo-
stat. The section was stained with H&E. For immunostain-
ing, sections were ﬁxed with 4% paraformaldehyde,
followed by heat-activated antigen retrieval (Vector Labo-
ratories, Burlingame, CA), and then incubated with goat
serum (5%) or 3% bovine serum albumin for 60 minutes.
Sections then were incubated with primary antibodies
indicated later for 60 minutes at room temperature. Pri-
mary antibodies to the Hþ/Kþ-ATPase a subunit (mouse
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September 2016 Imperfect Gastric Ulcer Healing 631monoclonal, 1:1000; Thermo Fisher Scientiﬁc, Inc, Waltham,
MA; or rabbit polyclonal, 1:1000; Santa Cruz, Biotechnology,
Inc, Dallas, TX), TFF2 (rabbit polyclonal, 1:200), gastric
intrinsic factor (GIF) (rabbit polyclonal, 1:100; Abcam,
Cambridge, MA), doublecortin-like kinase 1 (DCLK1)
(mouse monoclonal, 1:200, or rabbit polyclonal 1:1000;
Abcam), SOX9 (rabbit polyclonal, 1:1000; EMD Millipore,
Billerica, MA), NHE2 (rabbit polyclonal, 1:200), Ki67 (rabbit
polyclonal, 1:200; Abcam), pancreatic and duodenal ho-
meobox 1 (PDX1) (goat polyclonal, 1:5000; Abcam), gastrin
(rabbit polyclonal, 1:500; Dako, Carpinteria, CA), or SOX2
(mouse monoclonal, 1:200; Abcam) were used. Secondary
antibodies (Alexa 633–labeled goat anti-mouse IgGg1,
1:1000; Alexa 488–labeled goat anti-rabbit IgG, 1:1000;
1:500 for Hþ/Kþ-ATPase, TFF2, GIF, DCLK1, SOX9, NHE2,
Ki67, or SOX2; Alexa 633–labeled goat anti-rabbit IgG for
gastrin; Alexa 647–labeled donkey anti-rabbit IgG 1:1000
for SOX9 and Alexa 488–labeled donkey anti-goat IgG
1:1000 for PDX1) were incubated for 60 minutes at room
temperature. In some cases, Alexa 647–lectin GSII (1:100;
Life Technologies, Carlsbad, CA) and rhodamine–UEA-1
(1:100; Vector Laboratories) were incubated for 60 minutes
at room temperature. Nuclear staining was performed by
incubation with Hoechst 33342 (Invitrogen, Carlsbad, CA) at
1 mg/mL for 30 seconds. Sections were imaged with Zeiss
LSM710 confocal microscopy (Carl Zeiss, Oberkochen,
Germany).
Whole Mount Staining
Mouse intact or regenerated stomach tissues were ﬁxed
with 4% paraformaldehyde overnight at 4C, followed by
Dent’s ﬁxative (80% methanol þ 20% dimethylsulfoxide)
for 2 hours. After rehydration, tissues were incubated with
goat serum (4%) for 2 hours. Tissues then were incubated
with primary antibody to the Hþ/Kþ-ATPase a subunit
(rabbit polyclonal, 1:100; Santa Cruz) overnight at 4C,
followed by secondary antibodies (Alexa 633–labeled goat
anti-rabbit IgG, 1:400; Invitrogen), which were incubated
overnight at 4C. Nuclear staining was performed by incu-
bation with Hoechst 33342 (Invitrogen) at 10 mg/mL for 60
minutes. The tissue then was dehydrated with methanol and
a clearing agent was applied (2:1, benzyl benzoate:benzyl
alcohol). Whole-mount images were obtained via z-stack
using the Zeiss LSM710, and 3-dimensional images were
rendered by Imaris 7.7 (Bitplane, Zurich, Switzerland).
Western Blot Analysis
Extracted proteins from mouse intact or regenerated
stomach tissues were separated on a 1%–15% gradient
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(Bio-Rad), and transferred to a polyvinylidene diﬂuorideFigure 4. (See previous page). Mucous metaplasia in regen
days after acetic acid application. (A) Representative images sho
Scale bar: 1 mm. (B) Representative images show TFF2 (blue),
regenerated epithelium. White arrows in TFF2 and UEA-1 indica
50 mm. (C) Representative images show GIF (green), UEA-1 (wh
epithelium. Yellow arrows indicate cells that are GIF positive inmembrane (Immobilon-P; EMD Millipore). Membranes were
incubated for 1 hour with Odyssey blocking buffer (Li-Cor
Biosciences, Lincoln, NE), and then incubated with primary
antibodies to Hþ/Kþ-ATPase a subunit (mouse monoclonal,
1:10,000), GIF (rabbit polyclonal, 1:1000), TFF2 (rabbit
polyclonal, 1:1000), DCLK1 (rabbit polyclonal, 1:2000),
NHE2 (rabbit polyclonal, 1:1000), SOX9 (rabbit polyclonal,
1:2000), or GAPDH (mouse monoclonal 1:10,000). Mem-
branes then were washed and incubated for 1 hour in goat
anti-rabbit secondary antibody (Alexa Fluor 680, 1:1000
dilution; Invitrogen) or goat anti-mouse secondary antibody
(IR800 dye, 1:10,000; Li-Cor Biosciences). Fluorescent blots
were imaged and quantiﬁed using an Odyssey infrared im-
aging system (Li-Cor Biosciences). Immunoreactive bands
were quantiﬁed using background-corrected integrated
pixel intensity. Results were normalized to GAPDH, then
shown as fold change to value from intact tissue or wild-
type (WT) tissue.
RNA Sequence and Analysis
Stomach corpus regenerated tissue and corpus nonin-
volved tissue were harvested after 30 days of ulceration
under a dissection scope. Tissue was homogenized in TRI
Reagent. Extracted total RNA was puriﬁed by the PureLink
DNA Mini Kit (Life Technologies), followed by quantiﬁcation
with a Qubit Fluorometer (Life Technologies). The messenger
RNA (mRNA) was poly-A selected and converted into a
single-stranded cDNA library for Next Generation Sequencing
using the Illumina HiSeq 2500 (Illumina, Inc, San Diego, CA)
rapid sequencing system at the Cincinnati Children’s Hospital
Medical Center Sequencing Core. RNA sequencing (RNAseq)
was single-end 75–base pair reads with an average read
depth of 30 million per sample. All analyses were performed
in GeneSpring 12.6 (Agilent Technologies, Santa Clara, CA)
after removal of barcodes and primers.
Sequence data were aligned to the mouse reference
genome (mm10), with reference annotations produced by
the University of California, Santa Cruz.25 Reads with mul-
tiple mappings were removed, and aligned reads subse-
quently were ﬁltered on quality, including a quality
threshold of 30 or greater, and zero N values allowed. Reads
per kilobase per million reads were computed using quan-
tiﬁed read counts for each sample, subsequently normalized
using the DESeq algorithm and thresholded to 1. Normalized
counts were baselined to the median of control samples. The
expression data are available through NCBI Gene Expression
Omnibus (GSE76565).
Statistical Analysis
All values are reported from representative experiments
as the means ± SEM from multiple experiments. All resultserated epithelium. Immunoﬂuorescence was performed 30
w UEA-1 (green), GSII (red), and nuclei (Hoechst33342: blue).
UEA-1 (green), GSII (red), and nuclei (white) in the intact and
te cells that are TFF2 positive but UEA-1 negative. Scale bar:
ite), GSII (red), and nuclei (blue) in the intact and regenerated
the regenerated epithelium. Scale bar: 50 mm.
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Figure 6. Expression of
SOX2 in regenerated ep-
ithelium. Immunoﬂuores-
cence was performed 30
days after acetic acid appli-
cation. Images show SOX2
(red), Ki67 (green) or SOX9
(green), and nuclei
(Hoechst33342: blue) in the
intact and regenerated
epithelium. Scale bar: 50
mm.
September 2016 Imperfect Gastric Ulcer Healing 633were reproduced in at least 3 animals. Statistical signiﬁ-
cance was determined using an unpaired Student t test, or
1-way analysis of variance with the Dunnett multiple com-
parison post hoc test. A P value less than .05 was considered
signiﬁcant.
Expression values were compared between regener-
ated and noninvolved tissue from the same mouse stom-
ach using paired tests, with signiﬁcance deﬁned as a P
value less than .05 and a fold change magnitude greater
than 1.5 (n ¼ 1165 signiﬁcant genes) (Supplementary
Table 1). In addition, genes with known involvement in
gastric function were assessed for signiﬁcance and fold
change between regenerated and noninvolved tissues.
Heat maps were generated and clustered on both gene and
condition, using the Euclidean distance metric and average
linkage rule. Ontologic analyses and biological networking
were performed using GATACA (https://gataca.cchmc.
org), ToppGene Suite (https://toppgene.cchmc.org),26
ToppCluster (https://toppcluster.cchmc.org),27 and
Cytoscape3.28
All authors had access to the study data and reviewed
and approved the ﬁnal manuscript.Figure 5. (See previous page). Proliferation zone and stem ce
evaluated 30 days after ulcer induction. Sections of gastric reg
Top: Ki67 or SOX9 (green) and nuclei (Hoechst33342: red). Scale
SOX9 (green) co-stained with UEA-1 (white) and GSII (red) in
Sections of regenerated gastric epithelium were co-stained with
show DCLK1 (green), HK-ATPase (HK: red), and nuclei (blue)
magniﬁcation of intact and regenerated epithelium (right panel:
SOX9 (red) or (E) Ki67 (red), and nuclei (blue) in the intact and rResults
Regenerated Epithelial Appearance and
Gene Expression
Acetic acid–induced ulcers are a well-established rodent
model that has similar features of human ulcers.1 Consistent
with our previous observation,11 serosal application of
acetic acid induced necrosis of the local gastric epithelium,
covering the ulcerated area with dead cells. It is noted that
no HK-ATPase–positive cells were found in the ulcerated
area, whereas HK-ATPase–positive cells (bright red) with
bright Hoechst nuclear staining (indication of cell death)
were seen on the edge of the ulcerated area undergoing cell
death at day 2 (Figure 1A). At day 30, the ulcerated area was
visually covered by newly generated epithelium, although
microscopic observation showed the regenerated epithelial
appearance to be distinguished from normal gastric
epithelium, lacking HK-ATPase–positive cells (Figure 1B).
Characteristically, the regenerated surface epithelium was
connected to many glandular infoldings (Figure 2 and
Supplementary Movie 1). Sectioned gastric regenerated
tissue lacked HK-ATPase–positive cells (Figure 1C), and hadlls in the gastric regenerated epithelium. Gastric tissue was
enerated epithelium were stained with (A) Ki67 and (B) SOX9.
bar: 1 mm. In contrast, bottom: high magniﬁcation of Ki67 or
the intact and regenerated epithelium. Scale bar: 100 mm.
(C) DCLK1 and HK-ATPase, (D) SOX9, or (E) Ki67. (C) Images
in low magniﬁcation (left panel: scale bar: 1 mm) and high
scale bar: 50 mm). Double staining for (D) DCLK (green) and
egenerated epithelium. Scale bar: 50 mm.
Figure 7. Expression of UEA-1, GSII, Ki67, and SOX9 in the gastric antrum. (A) Sections of gastric antrum were stained with
UEA-1 (green), GSII (red), and nuclei (Hoechst33342: blue). Scale bar: 100 mm. (B and C) Left: Ki67 or SOX9 (green) and nuclei
(red), respectively; right: Ki67 or SOX9 (green) co-stained with UEA-1 (white) and GSII (red) in the sections of gastric antrum,
respectively. Scale bar: 100 mm.
634 Aihara et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 5signiﬁcantly reduced mucosal thickness vs normal epithe-
lium (Figure 1B). Consistent with our previous ﬁnding,11 we
observed up-regulation of TFF2 in the ulcer margin as
well as at the base of regenerated epithelium where HK-
ATPase–positive cells were lacking (Figure 1D). The changes
in TFF2 and HK-ATPase were conﬁrmed independently by
Western blot (Figure 3A and B) and RNAseq (Figure 3C).
RNAseq also showed up-regulation of C-X-C chemokinereceptor type 4 (CXCR4), a putative TFF2 receptor,16,29 in
the regenerated epithelium (Figure 3C). Interestingly, we
observed down-regulation of NHE2 in the regenerated tis-
sue (Figures 1E and 3A and B). The RNAseq data reported
that the gastric surface marker, Muc5ac, and the parietal cell
marker, HK-ATPase (Atp4a), H2 receptor (Hrh2), endocrine
cell marker, and chromogranin A (Chga) were down-
regulated (Figure 3C). In addition to down-regulation of
Figure 8. Expression of
PDX1 in regenerated epithe-
lium. Immunoﬂuorescence
was performed 30 days after
acetic acid application. (A)
Upper: PDX1 (red) and nuclei
(Hoechst33342: blue). Scale
bar: 1 mm. Lower: high
magniﬁcationofPDX1 (red) co-
stained with SOX9 (green) and
nuclei (blue) in the intact and
regenerated epithelium. Scale
bar: 50 mm. (B) PDX1 (red) with
SOX9 (green) and nuclei (blue)
in gastric antrum. Scale bar:
100 mm. (C) Low (upper panel:
scale bar: 1 mm) or high (lower
panel: scale bar: 100 mm)
magniﬁcation of gastrin (red)
and nuclei (blue) staining in the
regenerated epithelium. In
addition, images show low
(scale bar: 100 mm) or high
(from dotted rectangle on low-
resolution image, scale bar:
10 mm) resolution of gastrin
(red) and nuclei (blue) expres-
sion in gastric antrum.
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September 2016 Imperfect Gastric Ulcer Healing 637parietal cell markers, we observed signiﬁcant up-regulation
of a gastric atrophy marker,30 gastrokine 3 (Gkn3). How-
ever, we did not observe any changes of caudal type
homeobox (Cdx)1, Cdx2, or Muc2 expression, suggesting
that intestinal metaplasia does not arise in the corpus ulcer
healing process (Figure 3C).
Surface mucus marker ulex europaeus 1 (UEA-1) and
neck mucus marker Griffonia simplicifolia lectin II (GSII)
were expressed in their expected compartments of the gland
in the intact epithelium (Figure 4A and B). However, both
GSII and UEA-1–positive mucus staining also expanded into
the bottom of the gland in the regenerated tissue
(Figure 4A). GSII, which co-expresses with TFF2, is used as a
marker of spasmolytic polypeptide expressing metaplasia
(SPEM).31–33 SPEM has been documented in the ulcerated
area 7 days after ulceration induced by acetic acid.12,31
Consistent with other ﬁndings at early time points after
ulceration,34 we conﬁrmed that 30 days after ulceration
TFF2 co-expressed with GSII in the deep gland of the re-
generated epithelium (Figure 4B). The fold change values of
DMP777/Helicobacter felis–induced SPEM-related genes,
identiﬁed by RNAseq,35 correlated positively to our RNAseq
data, which showed borderline signiﬁcance in DMP777 and
nominal signiﬁcance in H felis. Results conﬁrmed that the
day 30 ulcer regenerated epithelium included SPEM line-
ages. Interestingly, UEA-1 also was found in TFF2-
expressing sites, whereas it was negative in the deepest
gland where TFF2 and GSII were positive (Figure 4B). GIF
and Bhlha15 (Basic Helix-Loop-Helix Family, Member A15,
also known as Mist1) were down-regulated in the regen-
erated epithelium (Figure 3A–C). GIF was found at the base
of the gland in the intact stomach (Figure 4C), but GIF-
positive cells were down-regulated dramatically in the re-
generated epithelium and were found only in the deepest
gland where GSII is positive and UEA-1 is negative
(Figure 4C). These data suggest that mature chief cells are
not present in the regenerated epithelium.Stem/Progenitor Zone in Regenerated Epithelium
Gastric epithelial proliferation normally occurs in the
isthmus region where we observe Ki67-positive cells
(Figure 5A). In contrast, Ki67-positive cells were found at
the base of regenerated epithelium, and Ki67 immunoreac-
tivity notably was localized in UEA-1– and GSII-positive cells
(Figure 5A). We also observed that SOX9 was up-regulated
in regenerated tissue (Figures 3A, B, D, and 5B), especially
within UEA-1– and GSII-positive cells deep in the gland,
whereas SOX9 expression was weak in the intact gastric
epithelium and co-localized with GSII (Figure 5B). The
expression pattern of SOX9 in regenerated epithelium
appeared deeper in the gland than that of Ki67. ResultsFigure 9. (See previous page). Gastric ulcer healing in TFF2
after ulcer induction. Gastric ulcer size was measured and data a
at P < .05 vs WT. (B) Sections of gastric intact epithelium or ulce
UEA-1 (green), GSII (red) and nuclei (Hoechst33342: blue). Scale
TFF2 KO at day 30 were dual-stained for H,K-ATPase (HK: red) a
(red). Left panel: low magniﬁcation (scale bar: 1 mm), right panesuggested that the stem/progenitor and proliferation zone
both are present at the gland base of regenerated epithe-
lium. In the RNAseq data, we found down-regulation of
Tnfrsf19 (Tumor necrosis factor receptor superfamily,
member 19, also known as Troy), Bmi1 (B lymphoma Mo-
MLV insertion region 1 homolog), and Msi1 (Musashi RNA-
binding protein 1), whereas we observed up-regulation of
Prom1, SOX9, and SOX2 (Figure 3D). SOX2 was expressed in
both nuclei and cytoplasmic compartments in the neck/
isthmus of the mouse stomach (Figure 6), and was
expressed sporadically in the entire epithelium, consistent
with other ﬁndings.21,36 SOX2-positive cells are partially
positive for Ki67 or SOX9 in normal epithelium. Similarly,
SOX2 was partially expressed in Ki67- and SOX9-positive
cells in the regenerated epithelium. However, SOX2
expression was not strong in the base of the gland where
SOX9 was up-regulated, although it was highly expressed in
the earlier-described proliferation zone (Ki67) (Figure 6).
Because SOX9 also is expressed in the tuft cell, we
checked the expression pattern of another tuft cell marker:
DCLK1. It also has been reported that DCLK1-expressing
cells are expanded in an ulcer,12 as well as in response to
loss of parietal cells.37 We observed that DCLK1 was up-
regulated signiﬁcantly in the regenerated epithelium
(Figures 3A–C and 5C). Immunoﬂuorescence showed that
DCLK1-positive cells also expressed SOX9, whereas a large
number of SOX9-positive cells did not co-express with
DCLK1 (Figure 5D). However, Ki67 was not expressed in
DCLK1-positive cells (Figure 5E).
By using uninjured tissue, we also observed that GSII co-
localized with Sox9 and Ki67 in the bottom of antral glands,
and UEA-1–positive mucus was observed throughout the
pyloric gland (Figure 7). We observed up-regulation of
PDX1 in the regenerated epithelium, despite no expression
of PDX1 in the normal corpus epithelium (Figures 3C and
8A). PDX1 was expressed in the antral epithelium
(Figure 8B). However, gastrin (Figure 3C) or Lgr5
(Figure 3D) expression did not change in the corpus re-
generated tissue and gastrin-positive cell was not detected
in the regenerated epithelium (Figure 8C). These data sug-
gest that regenerated corpus epithelium may share some
antral features, but within the time frame evaluated there
was no induction of mature antral cell types in the regen-
erated corpus epithelium under our experimental
conditions.Role of TFF2/NHE2 in Ulcer Healing
TFF2 is secreted predominantly by gastric neck cells and
appears to have a central role in gastric injury and repair.
TFFs promote gastric healing after injury through moto-
genic (cell migratory) and anti-apoptotic activities.12,13,19,38KO mouse. (A) Gastric tissue was evaluated at 9 or 30 days
re presented as means ± SEM (N ¼ 6). *Signiﬁcant difference
r margin in TFF2 KO at day 9. Images show H&E staining and
bar: 100 mm. (C) Sections of gastric regenerated epithelium in
nd TFF2 (green) or NHE2 (green), and UEA-1 (green) and GSII
l: high magniﬁcation (scale bar: 100 mm).
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Figure 11. Gastric
epithelium in NHE2 KO
mouse. Immunoﬂuores-
cence was performed in
NHE2 KO mouse stomach.
(A) Sections of NHE2 KO
stomach were stained with
SOX9 (green) and nuclei
(Hoechst33342: red) or
SOX9 (red), UEA-1 (white)
and GSII (red). (B) DCLK1
(green), SOX9 (red), or (C)
Ki67 (red), and (D) nuclei
(blue), or PDX1 (red), SOX9
(green), and nuclei (blue).
Scale bars: 50 mm.
September 2016 Imperfect Gastric Ulcer Healing 639We previously observed that TFF2 was up-regulated even at
day 9 after ulceration,11 and sustained an increase at day 30
(Figure 1). Although ulcer healing was delayed signiﬁcantly
in the TFF2 KO mouse stomach (Figure 9A), regeneration ofFigure 10. (See previous page). Gastric epithelium in NHE2 K
mice. (A) Data show Western blot images of HK-ATPase (HK)
analysis of Western blots as in panel A, with results normalized
to intact epithelium, means ± SEM (N ¼ 4). *Signiﬁcant differenc
high- (right panel, scale bar: 100 mm) magniﬁcation images of NH
and TFF2 (green), or UEA-1 (green) and GSII (red), respectiv
(Hoechst33342: white) in NHE2 KO mouse stomach. Scale bar:the epithelium was observed at day 30 even in TFF2 KO
mice, including sustained loss of HK-ATPase (Figure 9C).
The expression pattern of UEA-1– and GSII-positive cells
was similar to WT regenerated epithelium and we observedOmouse. Gastric tissue was obtained from WT and NHE2 KO
, TFF2, NHE2, SOX9, or GAPDH as indicated. (B) Compiled
to GAPDH. Results are presented as fold changes normalized
e at P < .05 vs WT. (C) Low- (left panel, scale bar: 1 mm) and
E2 KO mouse stomach, showing H&E, HK-ATPase (HK: red)
ely. (D) TFF2 (blue), UEA-1 (green), GSII (red), and nuclei
50 mm.
Figure 12. Expression of SOX2 in NHE2 KO mouse stomach. Immunoﬂuorescence was performed in NHE2 KO mouse
stomach. Sections of NHE2 KO stomach were stained with (A) SOX2 (red), SOX9 (green), or (B) Ki67 (green), and nuclei
(Hoechst33342: blue). Scale bars: 50 mm.
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C). In addition, NHE2 was down-regulated in both intact and
regenerated epithelium (Figure 9C), consistent with our
previous observation that NHE2 expression was low in the
TFF2 KO stomach.16 These data suggest that TFF2 is
involved most prominently in the initial closure of an ulcer,
but only slows re-epithelialization.
TFF-dependent repair of (at least microscopic) gastric
lesions requires the NHE2 Na/H exchanger isoform.16 In
normal tissue, we observed NHE2 expression in the surface
epithelium and also in the deep gland, whereas we observed
down-regulation of NHE2 in regenerated tissue (Figure 1E).
Because we observed the down-regulation of NHE2 in re-
generated epithelium, we considered the lack of NHE2 could
contribute to TFF2 up-regulation or generation of the poor
appearance of regenerated epithelium. To test this hypoth-
esis, we compared some outcomes in the ulcer regenerated
tissue with the healthy NHE2 KO stomach. In the NHE2 KO
corpus, HK-ATPase and GIF protein was down-regulated
signiﬁcantly (Figure 10A and B), whereas TFF2 was up-
regulated markedly deep in the gland and co-localized
with GSII (Figure 10A–C). UEA-1–positive cells, also found
deep in the gland, were co-localized with TFF2 or GSII(Figure 10C and D). In addition, we found that DCLK1 was
up-regulated signiﬁcantly in NHE2 KO gastric epithelium,
whereas there was no difference in SOX9 expression be-
tween WT and NHE2 KO stomach (Figure 10A and B). SOX9
was found deep in the gland as well as DCLK1-positive cells
(Figure 11A and B). Ki67-positive cells also were observed
deep in the gland, and did not overlap with DCLK1-positive
cells (Figure 11C). Similar to ulcer regenerated epithelium,
SOX2 was partially expressed in Ki67- and SOX9-positive
cells in the NHE2 KO stomach throughout the entire
epithelium (Figure 12A and B). On the other hand, we also
observed that PDX1 was expressed throughout the NHE2
KO mouse corpus epithelium (Figure 11D). When combined,
these results suggest that NHE2 has a role in the mainte-
nance as well as construction of a normal gastric epithelium.
Long-Term Monitoring of Regenerated Epithelium
We monitored ulcer healing for up to 8 months to
determine how long it takes to restore a normal gastric
epithelium after an initial ulceration. In the same experi-
mental series, we asked if the 30-day regenerated epithe-
lium was differentially susceptible to subsequent damage.
We inoculated low amounts of Sydney strain 1 H pylori
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(Figure 13A). We visually observed that ulcer regenerated
epithelium was disrupted by H pylori 14 days after inoc-
ulum (44 days after ulcer) (Figure 13B and C). It should be
noted that no ulcer was observed in other sites of the
stomach, suggesting that the regenerated epithelium de-
fense is relatively weak. H pylori colonization in the ulcer-
ated site was not consistently higher than that of uninjured
sites (Figure 13D). The disruption of regenerated epithelium
by H pylori did not heal by 8 months later (Figure 13B and
C), although H pylori colonization in the stomach tended to
decrease over time (Figure 13D).
At 44 days after ulceration without H pylori, HK-ATPase
largely was lacking in regenerated epithelium. Then at 4 and
8 months after ulceration without H pylori, HK-ATPase
expression began to return slowly, although H pylori
signiﬁcantly suppressed the return of HK-ATPase
(Figure 13E). At 4 months, TFF2 and NHE2 sustained up-
regulation and down-regulation in the regenerated epithe-
lium, respectively (Figures 13E and 14), with TFF2 showing
strong expression in the ulcerated site with H pylori. SOX9
was up-regulated signiﬁcantly in regenerated epithelium
with and without H pylori (Figure 13E). SOX9, Ki67, GSII,
and UEA-1 expression patterns were similar to those in the
day 30 regenerated epithelium (Figure 14). However, dis-
tribution of SOX9 and Ki67 was similar to non–H pylori
conditions (Figure 14).
At 8 months after ulceration without H pylori, we clearly
observed HK-ATPase and NHE2 expression in the regener-
ated epithelium and a decrease of TFF2 in the bottom of the
gland (Figures 13E and 15). Furthermore UEA-1, GSII, Ki67,
and SOX9 expression patterns became more similar to
normal gastric epithelium, although the height of epithelium
still was shorter (Figure 15). Conversely, no recovery of HK-
ATPase and NHE2 was found in the relapsed ulcer site
caused by H pylori, and TFF2 expression remained high
(Figure 13E). In addition, we observed a strong up-
regulation of Ki67 distribution and SOX9 in the ulcerated
site as well as intact area (Figure 15), suggesting that H
pylori also affects the intact area at this late time point.
However, only in the ulcerated area was UEA-1 co-localized
with GSII. These results suggest that ulcer regenerated
epithelium takes more than 8 months to return to normal,
and has the potential to progress to further damage, with
further insulting injury to the gastric mucosa.Discussion
We have shown using a mouse model that ulcer regen-
erated epithelium is characterized by abnormal epithelium
that is sustained for almost half a lifetime. Furthermore,
repaired tissues are more susceptible to subsequent
damage. Consistent with this, in human beings, long-term
follow-up studies (up to 17 years) have shown that gastric
recurrence or cancer development still is observed in many
ulcer patients, even with successful H pylori eradication.5
The gastric mucosa is exposed to acid and other chemical
hazards, including food intake, assuming that there is a high
chance to receive several challenges during ulcer healing. Inthe acetic acid–induced ulcer rodent model, several reports
have shown that administration of nonsteroidal anti-
inﬂammatory drugs or H pylori causes an ulcer in the area
where the initial ulcer had healed,10,39,40 although why an
offense-induced relapse ulcer occurs at the same site or
near the site still is unknown. In the present study, we
observed that H pylori causes ulcer relapse, speciﬁcally at
the site of visually healed regenerated epithelium. In addi-
tion, H pylori–infected regenerated epithelium sustains
metaplasia and morphologic abnormalities. The low inoc-
ulum of H pylori that we used in the present study explains
why it was unable to generate inﬂammation in the intact
gastric epithelium, and our work suggests that the regen-
erated epithelium has weakened defenses against H pylori.
We found that metaplasia occurs in the regenerated
epithelium and the metaplastic state is sustained for at least
4 months during normal ulcer healing. Previous studies
have shown that a loss of parietal cells induces metaplasia
in the stomach.12,19,24,38 It has been reported that DCLK1 is
up-regulated in response to a loss of parietal cells and
metaplasia, including ulcerated tissue, but its functional role
remains unknown.12,37 Because DCLK1-positive cells were
not positive for Ki67, they likely do not function as stem/
progenitor cells. In the ulcer, UEA-1–positive cells expanded
deep into the gland along with GSII- or TFF2-positive cells.
Maloum et al41 also observed an increase in the number of
UEA-1–positive cells that were found deep in the gland,
along with mucous metaplasia, a loss of parietal cells, and
down-regulation of MUC5ac. UEA-1 binds a-L-fuco-
se–containing glycoproteins. It has been reported that some
human TFF2 contains unusual fucosylated oligosaccha-
ride,42 but we observed UEA-1 staining deep in the gland of
regenerated epithelium in TFF2 KO mice. Fucosylation is
involved in many physiological and pathologic processes
such as development, cell proliferation, and inﬂammation.43
We observed an increase in the number of UEA-1–positive
cells, but it is unclear if this expansion of staining simply is
owing to more cells of a deﬁned type, such as gastric
foveolar hyperplasia, or an expansion of fucosylation among
a diverse set of cell types.
We reported that TFF2 plays an important role in gastric
epithelial restitution through CXCR4 in response to micro-
scopic damage.16,44 The surface epithelial/metastasis
markers TFF2 and CXCR4 are up-regulated and the former is
conﬁrmed to be widely distributed deep in the regenerated
gastric gland. It also has been reported that CXCR4 is up-
regulated at the ulcer granulation tissue and this expres-
sion is inhibited by acetylacetic acid administration, resulting
in delayed ulcer healing.45 In the present study, we showed
that ulcer healing was delayed in the TFF2 KO mouse stom-
ach, although we observed regenerated epithelium. This
suggests that TFF2 may be involved in the regulation of
proliferation as well. It also has been reported that TFF2
contributes to proliferation.46 On the other hand, it has been
reported that H pylori accelerates the progression of gastritis
to dysplasia (6 months) in the TFF2 KO mouse stomach,
although the development of atrophy and epithelial hyper-
plasia appeared 19 month after H pylori inoculation in the
wild-type mouse stomach.47 We observed that TFF2 is
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Figure 14. Morphology of gastric regenerated epithelium at 4 months after ulceration. Gastric ulcer was induced by
topical serosal application of acetic acid. In some animals, a single gavage of 106 H pylori was performed 30 days after ulcer
induction. Results are compared from the same tissue and sectioning series, although adjacent sections are not always
presented. Sections of uninfected (control) or H pylori–infected tissues are used. Images show dual staining for HK-ATPase
(HK: red) and TFF2 (green), HK-ATPase (HK: red) and NHE2 (green), or UEA-1 (green) and GSII (red), and triple staining for
Ki67 or SOX9 (green) with UEA-1 (white) and GSII (red). Scale bar: 1 mm. For Ki67 and SOX9, high-magniﬁcation images of
regenerated epithelium are shown in the yellow box. Scale bar: 100 mm.
September 2016 Imperfect Gastric Ulcer Healing 643up-regulated in the ulcerated area inH pylori infection even 8
months after an ulcer episode. Furthermore, it has been re-
ported that TFF2 acts as a tumor suppressor in gastric
carcinogenesis and TFF2 mRNA and protein are down-
regulated in gastric adenomas,13,48,49 these results suggest
that up-regulation of TFF2 contributes to prevent cancerFigure 13. (See previous page). Gastric regenerated epitheli
Schematic of experimental timeline. A single gavage of 106 H py
was evaluated at 14 days (44 days after ulceration), 3 months
ceration) after H pylori inoculation. (B) Gross morphology at eac
Control tissue was from mice uninfected with H pylori. (C) Gastric
SEM (N ¼ 5–7). *Signiﬁcant difference at P < .05 vs negative
control (c) gastric tissue was collected from the same mouse, ho
plates to obtain colony-forming units (CFU). Data are presented
infected with H pylori. (E) HK-ATPase, TFF2, NHE2, or SOX9 m
change normalized to the nonulcerated region of the uninfected
intact region (ulcer -, H pylori -). #P < .05 vs ulcer region in noprogression in the ulcer regenerated gastric epithelium. We
did not detect any cancer-like morphology even 8 month
after ulceration in the wild-type mouse stomach. Thus,
up-regulation of TFF2 is likely a necessary event in regen-
erated or inﬂamed tissue, which could prevent further
developing pathologic changes in the long term.um at long-term period, and ulcer relapse by H pylori. (A)
lori was performed 30 days after ulcer induction. Gastric ulcer
(4 months after ulceration), or 7 months (8 months after ul-
h experimental time point after inoculation with 106 H pylori.
ulcer size was measured and data are presented as means ±
H pylori. (D) Harvested ulcer regenerated (u) or nonulcerated
mogenized, and H pylori was cultured on Columbia blood agar
as CFU/g tissue (N ¼ 4). No CFU was detected in mice not
RNA was detected by real-time PCR. Data are shown as fold
group (ulcer -, H pylori -). Means ± SEM (N ¼ 5–7). *P < .05 vs
H pylori inoculation group (ulcer þ, H pylori -).
Figure 15. Morphology of gastric regenerated epithelium at 8 months after ulceration. Gastric tissue was isolated 8
month after ulcer induction. Results are compared from the same tissue and sectioning series, although adjacent sections are
not always presented. Sections of uninfected (control) or H pylori–infected tissues are used. Images show dual staining for HK-
ATPase (HK: red) and TFF2 (green), HK-ATPase (HK: red) and NHE2 (green), or UEA-1 (green) and GSII (red), and triple staining
for Ki67 or SOX9 (green) with UEA-1 (white) and GSII (red). Scale bar: 1 mm. For Ki67 and SOX9, high-magniﬁcation images of
regenerated epithelium are shown in the yellow box. Scale bar: 100 mm.
644 Aihara et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 5We previously reported that NHE2 plays a novel (albeit
unknown) role as an effector of TFF2 in gastric surface
epithelial restitution.16 We observed the down-regulation
of NHE2 in the regenerated epithelium where TFF2 is
up-regulated. This suggests that the regenerated epithelium
has a weakened defense against insult, which may explain
why a low abundance of H pylori selectively could relapse the
ulcer at the site of the regenerated tissue. In the present study,
we observed that the number of parietal cells are decreased in
NHE2 KO corpus. This is consistent with another ﬁnding that
NHE2 KO stomachs have fewer parietal cells with hyperpla-
sia/atrophy.15 The same group also suggested that NHE2 is
essential for parietal cell long-term viability.50 It is likely that
NHE2 deletion leads to a loss of parietal cells, resulting in the
generation of abnormal epithelium, which is similar to ulcer-
induced regenerated epithelium. Although NHE2 may be
involved in cell differentiation, further investigation will beneeded to determine whether NHE2 affects the local ionic
environment or directly alters the cell differentiation pathway
through another mechanism.
Stem cells in the gastric corpus epithelium have not been
fully identiﬁed yet, although proliferating cells normally are
detected in the isthmus. We observed strong proliferation
activity in the base of regenerated epithelium where the
UEA-1, GSII, and TFF2 abnormally is expressed at 30 days
after ulceration. In addition, SOX9 was up-regulated in the
same region, and returned to normal expression levels
during long-term ulcer healing. We also observed that SOX2,
which recently was reported as a gastric corpus stem cell
marker,21 was up-regulated in the regenerated epithelium,
although it does not speciﬁcally appear in the proliferative
(Ki67þ) compartment. SOX9 reportedly is up-regulated
within mucous metaplasia or gastric carcinoma.22–24 Gupta
et al22 reported that up-regulated SOX9 co-expressed with
September 2016 Imperfect Gastric Ulcer Healing 645GSII, and some SOX9-positive cells showed proliferating
activity. Although SOX9 marks tuft cells and mucous meta-
plasia in our current experiments, some SOX9-positive cells
also may be stem/progenitors to regenerate tissue in
response to injury. This could be resolved only using SOX9
lineage tracing experiments in the regenerated epithelium.
Lgr5þ cells now are recognized as the stem cell in antrum,
small intestine, and colon,17 but the expression of Lgr5 in
the adult corpus is limited. We did not see any changes of
Lgr5 mRNA in the regenerated tissue. It is reported that
Lgr5þ cells are not involved in developing metaplasia in
mouse corpus.19 Thus, Lgr5þ cells are unlikely to play any
role in ulcer regeneration in the corpus. More recently,
Troy-positive cells were expressed at the corpus gland
base in a subset of differentiated chief cells and showed
that sorted Troy-positive chief cells generate long-lived
gastric organoids, and these cultures were differentiated
toward the mucus-producing cell lineages of the neck and
pit regions.12,20 Troy has been proposed as a marker of
quiescent stem-like cells, but Troy mRNA did not change in
the regenerated epithelium. However, it is possible that
Lgr5þ cells or Troy-positive cells give rise to progenitor
cells, although they do not renew themselves. Further
studies will be needed to identify the stem cells that
respond to regenerate the damaged gastric epithelium.
A central question is whether such outcomes occur in
human beings. In human beings there is some limited evi-
dence that there is a longer time for recovery of parietal
cells after injury. Blom51 showed that parietal cells did not
reappear until 3 months after ulcer repair, and even by 8–9
months the number of parietal cells in the regenerated
gastric mucosa never reached normal levels. We observed
that PDX1 was increased in the regenerated epithelium.
Although regenerated epithelium may have features of
antral epithelium based on the expression patterns of
mucus, SOX9, and PDX1, we did not detect any genes of
mature antral cell types, such as gastrin. Other investigators
also found PDX1 expression in the adjacent gastric gland in
atrophic corpus gastritis.52 They suggested that PDX1 may
play a role in the initiation of metaplasia.52 It also has been
reported that overexpression of transforming growth factor-
a stimulated PDX1 throughout corpus atrophic epithelium
with up-regulation of TFF2 in the deep gland.53 Importantly,
they found that inhibition of PDX1 by anti–epidermal
growth factor antibody led to an increase in the number of
parietal cells.53 More recently, the same group found that
inhibition of mitogen-activated protein kinase (downstream
of epidermal growth factor-receptor signaling) regresses
metaplasia in the stomach and turned on the normal gastric
gland lineage, including the appearance of parietal cells.54
Our RNAseq analyses showed that transforming growth
factor-a and epidermal growth factor receptor were up-
regulated in the regenerated epithelium. Thus, these ﬁnd-
ings could provide an explanation of why differentiation to
parietal cells was slow in the regenerated epithelium in our
ulcer model. Further studies will be needed to investigate
this point.
We conclude that even after visual evidence of healing
from gastric ulceration, it cannot be assumed that thetissue is normal. The gene expression proﬁle and
morphology of the regenerated epithelium is abnormal in
mice for the long term, and this can contribute to further
damage. This is especially important because the gastric
epithelium is exposed continually to harsh environments
and is exposed commonly to the pathogen H pylori. In
human patients, the ulcer recurrence rate is varied among
the studies as well as countries, but overall there is a
concurrence regarding the beneﬁcial effect of H pylori
eradication or anti-ulcer medicine on ulcer recurrence.
Laine et al55 observed a 20% ulcer recurrence rate at 6
months in patients with successful H pylori eradication and
nonsteroidal anti-inﬂammatory drug users. They also re-
ported that the ulcer recurrence rate was increased over
time (ie, 6 months, 0%; 12 months, 7.5%; 18 months, 10%;
and 24 months, 10%) in patients in whom H pylori was
eradicated.56 We speculate that the regenerated epithelium
in patients may be molecularly and cellularly abnormal for
years, and that this increases the risk for a variety of
gastric disorders. Further study is needed in human pa-
tients because it may be necessary to develop a more
rigorous diagnostic criterion for ulcer healing as an op-
portunity to protect against prevention of further damage.References
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